The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
A plasticity-based theory of the pathogenesis of Alzheimer's disease.
Abstract
Amyloid plaques (APs) and neurofibrillary tangles (NFTs) are the two diagnostic markers of Alzheimer's disease (AD). The neuropsychological features of AD are closely correlated with the distribution of the NFTs and therefore favor a disease process revolving around neurofibrillary degeneration. The genetics, however, favor a disease process revolving around the APs, principally because mutations in the amyloid precursor protein (A beta PP) are sufficient to cause AD. The inability to reconcile these two aspects of AD has prevented the formulation of a unified theory of pathogenesis. It is interesting to note that all genetic causes and risk factors of AD can increase the physiological burden of neuroplasticity. My hypothesis is that the resultant intensification of the plasticity burden leads to an initially adaptive upregulation of tau phosphorylation and A beta PP turnover, to the subsequent formation of NFTs and APs as independent consequences of excessive plasticity-related cellular activity, and to the eventual loss of neurons, dendrites, and synapses as the ultimate expression of plasticity failure. The two pathological markers of AD are therefore independent manifestations of a more fundamental process through which the many different genotypes of AD trigger an identical clinical and neuropathological phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pattern is consistent with the hypothesis that AD pathology spreads centrifugally from limbic/paralimbic to higher-order association cortices (Mesulam, 2000).”
From Dynamics of Gray Matter Loss in Alzheimer's Disease (2003) · cites this paper as Mesulam, 2000
Citations
Cites
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 953
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795
Research works printed but not linked: 2
- Masliah E. et al.1995. Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice.InResearch Advances in Alzheimer's Disease and Related Disorders. K. Iqbal J. A. Mortimer B. Winbladet al. Eds.: 406–414. John Wiley and Sons. New York.
- Trojanowski J.Q., 1993, From pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease, Clin. Neurosci., 1, 184
Cited by
Sorted by citations
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Toga, A. W., Thompson, P. M., & Sowell, E. R. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.007 · Cited by 872
Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00089-3 · Cited by 796
ApoE genotype accounts for the vast majority of AD risk and AD pathology
Raber, J., Huang, Y., & Ashford, J. W. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.023 · Cited by 599
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Morris, G. P., Clark, I. A., & Vissel, B. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0135-5 · Cited by 522
Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia
Thompson, P. M., Hayashi, K. M., Sowell, E. R., Gogtay, N., Giedd, J. N., Rapoport, J. L., de Zubicaray, G. I., Janke, A. L., Rose, S., Semple, J. M., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.071 · Cited by 396
Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's Disease
de Haan, W., Mott, K. K., van Straaten, E. C. W., Scheltens, P., & Stam, C. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002582 · Cited by 400
Brain development and aging: Overlapping and unique patterns of change
Tamnes, C. K., Walhovd, K. B., Dale, A. M., Østby, Y., Grydeland, H., Richardson, G., Westlye, L. T., Roddey, J. C., Hagler, D. J., Due-Tønnessen, P., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2012.11.039 · Cited by 287
Thompson, P. M., Hayashi, K. M., Dutton, R. A., Chiang, M., Leow, A., Sowell, E. R., de Zubicaray, G. I., Becker, J. T., López, O. L., Aizenstein, H. J., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.017 · Cited by 259
Maestú, F., de Haan, W., Busche, M. A., & DeFelipe, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101372 · Cited by 245
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
Demirtas-Tatlidede, A., Vahabzadeh-Hagh, A. M., & Pascual-Leone, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.020 · Cited by 236
Sterniczuk, R., Antle, M. C., LaFerla, F. M., & Dyck, R. H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.011 · Cited by 228
Hippocampal hyperperfusion in Alzheimer's disease
Alsop, D. C., Casement, M. D., de BAZELAIRE, C., Fong, T. G., & Press, D. Z. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.006 · Cited by 203
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes
Sterniczuk, R., Dyck, R. H., LaFerla, F. M., & Antle, M. C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.013 · Cited by 208
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 189
Neuroplasticity in Alzheimer's disease
Teter, B., & Ashford, J. W. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10441 · Cited by 170
Non-familial Alzheimer's disease is mainly due to genetic factors
Ashford, J. W., & Mortimer, J. A. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4307 · Cited by 151
Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
Lombardo, J. A., Stern, E. A., McLellan, M. E., Kajdasz, S. T., Hickey, G. A., Bacskai, B. J., & Hyman, B. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10879.2003 · Cited by 149
Microglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease
Das, R., & Chinnathambi, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03132-2 · Cited by 147
Gardini, S., Venneri, A., Sambataro, F., Cuetos, F., Fasano, F., MARCHI, M. D., Crisi, G., & Caffarra, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142547 · Cited by 143
Focal temporal pole atrophy and network degeneration in semantic variant primary progressive aphasia
Collins, J. A., Montal, V., Hochberg, D., Quimby, M., Mandelli, M. L., Makris, N., Seeley, W. W., Gorno‐Tempini, M. L., & Dickerson, B. C. (2016) · Brain · doi:10.1093/brain/aww313 · Cited by 145
Cortical hypermetabolism in MCI subjects: a compensatory mechanism?
Ashraf, A., Fan, Z., Brooks, D. J., & Edison, P. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2919-z · Cited by 143
Ikonomovic, M., Mufson, E., Wuu, J., Cochran, E., Bennett, D., & DeKosky, S. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5106 · Cited by 145
Changes in Plasticity Across the Lifespan
Oberman, L. M., & Pascual‐Leone, Á. (2013) · Progress in brain research · doi:10.1016/b978-0-444-63327-9.00016-3 · Cited by 134
Loewenstein, D., Acevedo, A., Luis, C. A., Crum, T. A., Barker, W., & Duara, R. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704101112 · Cited by 122
Structural MRI and Brain Development
Thompson, P. M., Sowell, E. R., Gogtay, N., Giedd, J. N., Vidal, C. N., Hayashi, K. M., Leow, A., Nicolson, R., Rapoport, J. L., & Toga, A. W. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67009-2 · Cited by 112
Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders
Bartzokis, G. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.001 · Cited by 97
Noninvasive brain stimulation to modulate neuroplasticity in traumatic brain injury
Villamar, M. F., Santos Portilla, A., Fregni, F., & Zafonte, R. (2012) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/j.1525-1403.2012.00474.x · Cited by 119
Structural networks in Alzheimer's disease
Reid, A., & Evans, A. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.11.010 · Cited by 94
Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
Forero, D. A., Casadesús, G., Perry, G. L., & Arboleda, H. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00439.x · Cited by 89
Mapstone, M. E., Lin, F. V., Nalls, M. A., Cheema, A. K., Singleton, A., Fiandaca, M. S., & Federoff, H. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.007 · Cited by 82
Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
Pietropaolo, S., Feldon, J., & Yee, B. K. (2008) · Behavioral Neuroscience · doi:10.1037/a0012520 · Cited by 84
Bigio, E. H., Hynan, L. S., Sontag, E., Satumtira, S., & White, C. L. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00385.x · Cited by 86
Scherr, M., Utz, L., Tahmasian, M., Pasquini, L., Grothe, M. J., Rauschecker, J. P., Grimmer, T., Drzezga, A. E., Sorg, C., & Riedl, V. (2019) · Human Brain Mapping · doi:10.1002/hbm.24517 · Cited by 77
Bedse, G., Romano, A., Cianci, S., Lavecchia, A. M., Pace, L., Elphick, M. R., LaFerla, F. M., Vendemiale, G., Grillo, C., Fabio Altieri, F., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131910 · Cited by 69
Protective effects of different exercise modalities in an Alzheimer’s disease-like model
Özbeyli, D., Sarı, G., Özkan, N., Karademir-Yilmaz, B., Yüksel, M., Çilingir‐Kaya, Ö. T., & ÇAKIR, Ö. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.044 · Cited by 68
Bellanti, F., Iannelli, G., Blonda, M., Tamborra, R., Villani, R., Romano, A., Calcagnini, S., Mazzoccoli, G., Vinciguerra, M., Gaetani, S., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160942 · Cited by 70
Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model
Niño, S. A., Morales-Martínez, A., Chi-Ahumada, É., Carrizales, L., Salgado‐Delgado, R., Pérez‐Severiano, F., Díaz-Cintra, S. Y., Jiménez-Capdeville, M. E., & Zarazúa, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00278 · Cited by 64
Belviranlı, M., & Okudan, N. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.030 · Cited by 62
Shao, Y., Mang, J., Li, P.-L., Wang, J., Deng, T., & Xu, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130831 · Cited by 62
Ally, B. A. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0310-7 · Cited by 58
ApoE-Dependent Plasticity in Alzheimer's Disease
Teter, B. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:167 · Cited by 59
The Neuroprotective Role of Creatine
Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 56
GAP-43 gene expression regulates information storagePreprint
Holahan, M. R., Honegger, K. S., Tabatadze, N., & Routtenberg, A. (2007) · Learning & Memory · doi:10.1101/lm.581907 · Cited by 56
Adamczuk, K., Weer, A. D., Nelissen, N., Chen, K., Sleegers, K., Bettens, K., Broeckhoven, C. V., Vandenbulcke, M., Thiyyagura, P., Dupont, P. J., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.04.001 · Cited by 58
Traumatic brain injury and its effects on synaptic plasticity
Albensi, B. C., & Janigro, D. (2003) · Brain Injury · doi:10.1080/0269905031000107142 · Cited by 51
Subfield-specific increase in brain growth protein in postmortem hippocampus of Alzheimer's patients
Rekart, J. L., Quinn, B., Mesulam, M. M., & Routtenberg, A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.060 · Cited by 51
Flaherty, L. T. (2013) · Routledge eBooks · doi:10.4324/9780203780589-9 · Cited by 49
The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease
Cheng, X., Wu, J., Geng, M., & Xiong, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.021 · Cited by 51
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2021.630172 · Cited by 47
The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes
Hansra, G. K., Popov, G., Banaczek, P. O., Vogiatzis, M., Jegathees, T., Goldsbury, C. S., & Cullen, K. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.009 · Cited by 47
Neuronal Activity and Amyloid Plaque Pathology: An Update
Ovsepian, S. V., & O’Leary, V. B. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150544 · Cited by 42
Cantanelli, P., Sperduti, S., Ciavardelli, D., Stuppia, L., Gatta, V., & Sensi, S. L. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00200 · Cited by 44
Ross, E. K., Kim, J. P., Settell, M. L., Han, S. R., Blaha, C. D., Min, H.-K. P., & Lee, K. H. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.12.056 · Cited by 45
Toga, A. W., Thompson, P. M., & Sowell, E. R. (2006) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.4.3.378 · Cited by 42
Neurotrophin secretory pathways and synaptic plasticity
Lim, K. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.003 · Cited by 41
Champagne, D. L., Rochford, J. M., & Poirier, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.016 · Cited by 41
Alzheimer’s Disease: Genes, Pathogenesis and Risk Prediction
Sleegers, K., & van Duijn, C. M. (2001) · Public Health Genomics · doi:10.1159/000064193 · Cited by 39
Hanseeuw, B. J., Dricot, L., Kavec, M., Grandin, C. B. G., Seron, X., & Ivanoiu, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.034 · Cited by 38
Klucken, J., McLean, P. J., Gómez‐Tortosa, E., Ingelsson, M., & Hyman, B. T. (2003) · Neurochemical Research · doi:10.1023/a:1026061021946 · Cited by 38
Probing neural circuit mechanisms in Alzheimer’s disease using novel technologies
Grieco, S. F., Holmes, T. C., & Xu, X. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02018-x · Cited by 37
Dubelaar, E. J. G., Mufson, E. J., ter Meulen, W. G., van Heerikhuize, J. J., Verwer, R. W. H., & Swaab, D. F. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000205143.16339.cd · Cited by 31
Baazaoui, N., Flory, M. J., & Iqbal, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160845 · Cited by 31
Alzheimer’s Disease and Neuronal Network Activity
Gleichmann, M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8100-3 · Cited by 29
Lin, X., Chen, L., Baglietto‐Vargas, D., Kamalipour, P., Ye, Q., LaFerla, F. M., Nitz, D. A., Holmes, T. C., & Xu, X. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105562 · Cited by 27
Williams, J. H., Wilcock, G. K., Seeburger, J. L., Dallob, A. L., Laterza, O., Potter, W. Z., & Smith, A. D. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt64 · Cited by 26
Differential expression of LMO4 protein in Alzheimer's disease
Leuba, G., Vernay, A., Vu, D., Walzer, C., Belloir, B., Kraftsik, R., Bouras, C., & Savioz, A. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00511.x · Cited by 23
Cortical Changes in Incipient Alzheimer's Disease
Prestia, A., Drago, V., Rasser, P. E., Bonetti, M., Thompson, P. M., & Frisoni, G. B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101191 · Cited by 29
Ye, M., Chung, H., An, Y. H., Lim, S.-J., Choi, W., Yu, A., Kim, J. S., Kang, M., Cho, S., Shim, I., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9458-x · Cited by 22
Clinical heterogeneity in familial Alzheimer’s disease
van der Flier, W. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30275-7 · Cited by 23
Neill, D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.004 · Cited by 22
Pooler, A. M., Polydoro, M., Wegmann, S., Pitstick, R., Kay, K. R., Sanchez, L., Carlson, G. A., Gómez‐Isla, T., Albers, M. W., Spires‐Jones, T. L., et al. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23411 · Cited by 21
A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories
Duchesne, S., Rousseau, L., Belzile, F., Welch, L., Cournoyer, B., Arseneau, M., Lapierre, V., Poulin, S., Potvin, O., & Hudon, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230772 · Cited by 24
Haubold, A., Peterson, B. S., & Bansal, R. (2012) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02539.x · Cited by 20
Cognitive neural plasticity during learning and recovery from brain damage
Raymont, V., & Grafman, J. H. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)57013-x · Cited by 20
Conducta simbólica y neuroplasticidad: ¿un ejemplo de coevolución gen-cultura?
Soler, E. B., & Carbonell, E. (2004) · Revista de Neurología · doi:10.33588/rn.3901.2004314 · Cited by 16
Roe, J. M., Dídac Vidal-piñeiro, A., Sørensen, Ø., Grydeland, H., Leonardsen, E. H., Iakunchykova, O. P., Pan, M., Mowinckel, A. M., Strømstad, M., Nawijn, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53548-z · Cited by 20
Gürel, B., Cansev, M., Koç, C., Öcalan, B., Çakır, A., Aydın, S., Kahveci, N., Ulus, İ. H., Şahin, B., Karayel‐Basar, M., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190730155926 · Cited by 16
Gardner, M. R., Baruah, V., Vargas, G., Motamedi, M., Milner, T. E., & Rylander, H. G. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.5.18 · Cited by 17
Liang, X., Xue, C., Zheng, D., Yuan, Q., Qi, W., Ruan, Y., chen, S., Song, Y., Wu, H., Lu, X., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1343926 · Cited by 15
Guo, Z., Liu, X., Hou, H., Wei, F., Chen, X., Shen, Y., & Chen, W. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.06.001 · Cited by 15
Fornix Stimulation Induces Metabolic Activity and Dopaminergic Response in the Nucleus Accumbens
Shin, H., Lee, S., Cho, H., Oh, Y., Kim, I. Y., Lee, K. H., Jang, D. P., & Min, H.-K. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01109 · Cited by 17
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Hroudová, J., & Fišar, Z. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111069 · Cited by 13
Neural network plasticity, BDNF and behavioral interventions in Alzheimer's disease
Hubka, P. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656858 · Cited by 12
Cognitive Stimulation: The Evidence Base for its Application in Neurodegenerative Disease
Marco, M. D., Shanks, M. F., & Venneri, A. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140505120145 · Cited by 12
Human Brain Myelination Trajectories Across the Life Span
Sherin, J. E., & Bartzokis, G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00015-4 · Cited by 11
Enriched odor exposure decrease tau phosphorylation in the rat hippocampus and cortex
Liao, K., Liu, D., & Zhu, L. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.040 · Cited by 11
Coconut oil ameliorates behavioral and biochemical alterations induced by D-GAL/AlCl3 in rats
Belviranlı, M., & Okudan, N. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148704 · Cited by 9
Reply to Biskup et al. and Tu et al.: Sex differences in metabolic brain aging
Goyal, M. S., Vlassenko, A. G., & Raichle, M. E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904673116 · Cited by 8
Malignant Synaptic Growth and Alzheimer‘s Disease
Newman, E. L., Shay, C. F., & Hasselmo, M. E. (2012) · Future Neurology · doi:10.2217/fnl.12.47 · Cited by 6
Legrand, D., Roberge, P., Vanasse, A., Carrier, N., & Bocti, C. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123746 · Cited by 5
PET Imaging of Epigenetic Influences on Alzheimer’s Disease
Couto, P. J., & Millis, R. M. (2015) · International Journal of Alzheimer's Disease · doi:10.1155/2015/575078 · Cited by 19
L’exploration en IRM des démences de type Alzheimer. Que peut-on voir sur un examen de routine ?
Salamon, G., Salamon, N., Johnson, N., Mongkolwat, P., Gitelman, D. R., Weıntraub, S., Mesulam, M. M., & Russell, E. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)70848-6 · Cited by 4
Dynamic Mapping of Alzheimer’s Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G. I., Janke, A. L., Sowell, E. R., Rose, S., Semple, J. M., Herman, D. H., Hong, M., Dittmer, S. S., et al. (2004) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-59300-0_8 · Cited by 4
National dementia research and development project
Park, S.-H., & Lee, J. (2018) · Journal of Korean Medical Association · doi:10.5124/jkma.2018.61.5.304 · Cited by 3
Alzheimer disease and neuroplasticity: New approaches and new targets in pharmacotherapy
Uzbay, T. I. (2012) · MARMARA PHARMACEUTCAL JOURNAL · doi:10.12991/201216404 · Cited by 3
Metadata
- Authors
- MESULAM, M. ‐.
- Affiliations
- Northwestern University (US)
- Corresponding author
- MESULAM, M.‐MARSEL
- ORCID
- MESULAM, M.‐MARSEL
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 924
- Issue
- 1
- Pages
- 42-52
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2061837100
- Cited by
- 130
- References
- 49
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 7 · 2021: 6 · 2020: 3 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 10
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns020285-15)
- National Institute on Aging (AG13854, P30AG013854)
- National Institute of Neurological Disorders and Stroke (NS 20285)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease pathogenesis, neuroplasticity, amyloid plaques, neurofibrillary tangles, tau phosphorylation, amyloid precursor protein, synaptic loss, neurodegeneration, genotype-phenotype correlation
- MeSH terms
- Alzheimer Disease, Brain, Humans, Neuronal Plasticity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review